Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis

被引:322
|
作者
Reed, Caitlin [1 ]
Bryant, Richard [2 ,3 ]
Ibrahim, Ashraf S. [1 ,3 ]
Edwards, John, Jr. [1 ,3 ]
Filler, Scott G. [1 ,3 ]
Goldberg, Robert [2 ,3 ]
Spellberg, Brad [1 ,3 ]
机构
[1] Harbor UCLA Med Ctr, Div Infect Dis, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA
[2] Univ Calif Los Angeles, Med Ctr, Dept Orbital & Ophthalm Plast Surg, Los Angeles, CA 90024 USA
[3] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90095 USA
关键词
D O I
10.1086/589857
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. It has been axiomatic that echinocandins ( e. g., caspofungin) are ineffective against mucormycosis. However, on the basis of preclinical data, we recently began treating rhino- orbital- cerebral mucormycosis ( ROCM) with combination polyene- caspofungin therapy. Methods. To determine the impact of polyene-caspofungin therapy, ROCM cases identified by an International Classification of Diseases, Ninth Revision search were retrospectively reviewed to gather data on demographic characteristics, clinical history, and outcomes. The predefined primary end point was success (i.e., the patients was alive and not in hospice care) at 30 days after hospital discharge. Results. Forty-one patients with biopsy-proven ROCM were identified over 12 years; 23 (56%) of these patients were Hispanic, and 34 (83%) were diabetic. Patients treated with polyene-caspofungin therapy (6 evaluable patients) had superior success (100% vs. 45%; P = .02) and Kaplan-Meier survival time (P = .02), compared with patients treated with polyene monotherapy. Patients treated with amphotericin B lipid complex had inferior success (37% vs. 72%; P= .03) and a higher clinical failure rate (45% vs. 21%; P = .04), compared with patients who received other polyenes. However, patients treated with amphotericin B lipid complex plus caspofungin had superior success (100% vs. 20%; P = .009) and survival time (P = .01), compared with patients who received amphotericin B lipid complex alone. The benefit of combination therapy, compared with monotherapy, was most pronounced in patients with cerebral involvement (success rate, 100% vs. 25%; P = .01). In multivariate analysis, only receipt of combination therapy was significantly associated with improved outcomes (odds ratio, 10.9; 95% confidence interval, 1.3-infinity; P = .02). Conclusions. Combination polyene-caspofungin therapy represents a promising potential alternative to polyene monotherapy for patients with ROCM. Randomized, prospective investigation of these findings is warranted.
引用
收藏
页码:364 / 371
页数:8
相关论文
共 50 条
  • [1] Rhino-orbital-cerebral mucormycosis
    Chen, I-Wen
    Lin, Cheng-Wei
    CANADIAN MEDICAL ASSOCIATION JOURNAL, 2019, 191 (16) : E450 - E450
  • [2] Rhino-Orbital-Cerebral Mucormycosis
    Gamaletsou, Maria N.
    Sipsas, Nikolaos V.
    Roilides, Emmanuel
    Walsh, Thomas J.
    CURRENT INFECTIOUS DISEASE REPORTS, 2012, 14 (04) : 423 - 434
  • [3] Rhino-orbital-cerebral Mucormycosis
    Niculae, Cristian-Mihail
    Craciun, Laura
    NEW ENGLAND JOURNAL OF MEDICINE, 2024, 390 (12):
  • [4] Rhino-Orbital-Cerebral Mucormycosis
    Maria N. Gamaletsou
    Nikolaos V. Sipsas
    Emmanuel Roilides
    Thomas J. Walsh
    Current Infectious Disease Reports, 2012, 14 : 423 - 434
  • [5] Bilateral Rhino-Orbital-Cerebral Mucormycosis
    Teixeira, Bruno Magalhaes
    Dias, Margarida Queiros
    Castela, Guilherme
    JAMA OPHTHALMOLOGY, 2024, 142 (07)
  • [6] The Diagnosis: Rhino-orbital-cerebral Mucormycosis
    不详
    CUTIS, 2014, 94 (04): : 195 - 196
  • [7] Rhino-orbital-cerebral mucormycosis and aspergillosis: differential diagnosis and treatment
    Susan Arndt
    Antje Aschendorff
    Matthias Echternach
    Tanja Daniela Daemmrich
    Wolfgang Maier
    European Archives of Oto-Rhino-Laryngology, 2009, 266 : 71 - 76
  • [8] Successful Treatment of Rhino-Orbital-Cerebral Mucormycosis in a Child With Leukemia
    Jensen, Thorbjorn S. R.
    Arendrup, Maiken C.
    von Buchvald, Christian
    Frandsen, Thomas L.
    Juhler, Marianne
    Nygaard, Ulrikka
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2017, 39 (04) : E211 - E215
  • [9] Rhino-orbital-cerebral mucormycosis and aspergillosis: differential diagnosis and treatment
    Arndt, Susan
    Aschendorff, Antje
    Echternach, Matthias
    Daemmrich, Tanja Daniela
    Maier, Wolfgang
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2009, 266 (01) : 71 - 76
  • [10] SURVIVAL FACTORS IN RHINO-ORBITAL-CEREBRAL MUCORMYCOSIS
    YOHAI, RA
    BULLOCK, JD
    AZIZ, AA
    MARKERT, RJ
    SURVEY OF OPHTHALMOLOGY, 1994, 39 (01) : 3 - 22